GlobalData
GlobalData

Hari Gorla

  • Home
  • Author: Hari Gorla

Future of Work sentiments up 12% in Q2 2021 as companies embrace hybrid workspaces, says GlobalData

The future of work is likely to be a mixture of work from home (WFH) and office work, according to sentiment analysis by GlobalData, a leading data and analytics company. The company’s Filing Analytics platform notes that ‘WFH’, ‘remote working’ and ‘video conferencing’ continue to be prominent keywords in all company filings, and, while discussions […]
Read more

AI and big data will continue to disrupt pharmaceutical sector, according to healthcare industry professionals surveyed by GlobalData

Artificial intelligence (AI) and big data will play a major role in optimizing pharmaceutical drug discovery and development process, as indicated by 24% and 25% of global healthcare industry professionals, respectively 23% of the surveyed healthcare industry professionals confirmed that their companies were currently using in AI to enhance drug discovery and development process with […]
Read more

2021 is a pivotal year for field of personalized neoantigen immuno-oncology therapeutics, says GlobalData

New immunotherapy agents in the oncology pipeline aim to predict the most important tumor antigens and formulate a personalized vaccine against them. With multiple catalysts coming up in Q4 2021, data from a number of early-stage biotech companies will have a profound impact on the industry’s sentiment regarding personalized neoantigen therapeutics, according to GlobalData, a […]
Read more

Marine, aviation and transit insurance in Asia-Pacific to reach US$14.5bn by 2025, forecasts GlobalData

The marine, aviation and transit (MAT) insurance industry in Asia-Pacific is projected to grow from US$11.2bn in 2019 to US$14.5bn in 2025, in terms of written premiums, according to GlobalData, a leading data and analytics company. GlobalData’s insight report, ‘Global Marine, Aviation and Transit Insurance Market to 2025 – Key Business Lines, Trends, Drivers, Challenges, […]
Read more

COVID-19 vaccine market set to reach $19.5bn by 2026

The size of the COVID-19 vaccine market across the seven major markets (7MM*) will increase from $13.6bn in 2021 to $19.5bn in 2026 at a compound annual growth rate (CAGR) of 7.6% should annual vaccination be required, according to GlobalData, a leading data and analytics company. COVID-19 vaccines based on mRNA technology dominate the 7MM […]
Read more

Card payments in Saudi Arabia to grow by 29.6% in 2021

Saudi Arabia’s card payments market, which has registered sustained growth for the past few years, is set to increase strongly by 29.6% in 2021. The increasing preference for electronic payments amid the COVID-19 pandemic and a surge in contactless payments are likely to drive the country’s card payments market between 2021 and 2025 at a […]
Read more

JP Morgan and Goldman Sachs were top M&A financial advisers by value and volume in North America for H1 2021, finds GlobalData

JP Morgan and Goldman Sachs were the top mergers and acquisitions (M&A) financial advisers in North America for H1 2021 by value and volume, respectively. JP Morgan advised on 167 deals worth US$419.4bn, which was the highest value among all the advisers. Meanwhile, Goldman Sachs led in volume terms having advised on 168 deals worth […]
Read more

Simpson Thacher & Bartlett and Kirkland & Ellis were top M&A legal advisers by value and volume in North America for H1 2021, finds GlobalData

Simpson Thacher & Bartlett and Kirkland & Ellis were the top mergers and acquisitions (M&A) legal advisers in North America for H1 2021 by value and volume, respectively. Simpson Thacher & Bartlett advised on 118 deals worth US$326.7bn, which was the highest value among all the advisers. Meanwhile, Kirkland & Ellis led in volume terms having […]
Read more

Seelos Therapeutics’ SLS-002 could be a strong competitior to Spravato for treatment of suicidal behavior, says GlobalData

Seelos Therapeutics has recently announced that the first patient has been dosed in the second part of its registrational study of SLS-002 (intranasal racemic ketamine) for acute suicidal ideation and behavior (ASIB) in patients with major depressive disorder (MDD). If approved SLS-002 would become only the second product approved specifically for ASIB, after Johnson & […]
Read more

Hero Electric aims for EV leadership with new business expansion plans in India, says GlobalData

Following the news that Hero Electric Vehicles, the electric arm of India’s leading two-wheeler company Hero MotoCorp, will invest INR7bn as part of its business expansion plans by 2025; Bakar Sadik Agwan, Senior Automotive Consulting Analyst at GlobalData, a leading data and analytics company, offers his view: “Hero Electric mulling investments in electric two-wheeler segment […]
Read more

Egencia’s air-rail comparison tool signals shift towards a low-cost, sustainable future for business travel, says GlobalData

Travel management company (TMC) Egencia Travel’s game-changing new tool, which enables business travelers to compare rail alternatives to flights before purchase, will meet the modern-day demands of corporate travel programs, says GlobalData, a leading data and analytics company. Craig Bradley, Associate Travel & Tourism Analyst at GlobalData, commented: “Cost and sustainability are key factors in […]
Read more
1 29 30 31 32 33 60